Literature DB >> 23203362

Defining treatment as usual for attenuated psychosis syndrome: a survey of community practitioners.

Elizabeth Jacobs1, Emily Kline, Jason Schiffman.   

Abstract

OBJECTIVE: Schizophrenia and related disorders are often preceded by attenuated psychosis symptoms, sometimes referred to as attenuated psychosis syndrome, but little is known about practitioners' current practices with regard to this population. This survey of clinical psychologists, psychiatrists, and general practitioners explored treatment as usual of attenuated psychosis syndrome.
METHODS: In 2008, a total of 1,500 practitioners were mailed surveys containing vignettes describing individuals with full, attenuated, and no psychotic symptoms and a checklist of possible interventions. Practitioners were asked to select interventions that would help or harm the individual.
RESULTS: The responses (N=293, 20%) suggested that practitioners treated attenuated psychosis syndrome similarly to full-threshold psychosis. The use of antipsychotic medications to treat attenuated symptoms was endorsed by 69% of practitioners. Family support groups and family involvement were endorsed by 58% and 49% of respondents, respectively.
CONCLUSIONS: Further development and dissemination of practice guidelines may help providers treat attenuated psychosis syndrome.

Entities:  

Mesh:

Year:  2012        PMID: 23203362      PMCID: PMC3733093          DOI: 10.1176/appi.ps.201200045

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  14 in total

1.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

2.  Antipsychotic treatment of UHR ('prodromal') individuals.

Authors:  Alison R Yung
Journal:  Early Interv Psychiatry       Date:  2010-08       Impact factor: 2.732

3.  Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.

Authors:  Antonio Preti; Matteo Cella
Journal:  Schizophr Res       Date:  2010-08-21       Impact factor: 4.939

4.  Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosis.

Authors:  Kyung Ran Kim; Su Young Lee; Jee In Kang; Bo Ra Kim; Soo-Hee Choi; Jin Young Park; Eun Lee; Suk Kyoon An; Jun Soo Kwon
Journal:  Early Interv Psychiatry       Date:  2011-05       Impact factor: 2.732

5.  Beliefs about the helpfulness of interventions for mental disorders: a comparison of general practitioners, psychiatrists and clinical psychologists.

Authors:  A F Jorm; A E Korten; P A Jacomb; B Rodgers; P Pollitt
Journal:  Aust N Z J Psychiatry       Date:  1997-12       Impact factor: 5.744

Review 6.  Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents.

Authors:  Christoph U Correll; Harold E Carlson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-07       Impact factor: 8.829

7.  Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort.

Authors:  Kristin S Cadenhead; Jean Addington; Tyrone Cannon; Barbara Cornblatt; Thomas McGlashan; Diana Perkins; Larry Seidman; Ming Tsuang; Elaine Walker; Scott Woods; Robert Heinssen
Journal:  Early Interv Psychiatry       Date:  2010-08       Impact factor: 2.732

Review 8.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

9.  Indicated prevention of schizophrenia.

Authors:  Joachim Klosterkötter
Journal:  Dtsch Arztebl Int       Date:  2008-07-25       Impact factor: 5.594

10.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01
View more
  5 in total

1.  Clinical High Risk Controversies and Challenge for the Experts.

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

2.  Considerations for the development and implementation of brief screening tools in the identification of early psychosis.

Authors:  Jason Schiffman
Journal:  Schizophr Res       Date:  2018-03-07       Impact factor: 4.939

3.  Evaluating the tendencies of community practitioners who actively practice in child and adolescent psychiatry to diagnose and treat DSM-5 attenuated psychotic syndrome.

Authors:  Helin Yilmaz Kafali; Mireia Solerdelcoll; Lena Vujinovic; Dmytro Martsenkovskyi; Sewanu Awhangansi; Camille Noel; Emre Bora; Celso Arango
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-10-20       Impact factor: 5.349

4.  Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.

Authors:  Paolo Fusar-Poli; Andrea De Micheli; Marco Cappucciati; Grazia Rutigliano; Cathy Davies; Valentina Ramella-Cravaro; Dominic Oliver; Ilaria Bonoldi; Matteo Rocchetti; Lauren Gavaghan; Rashmi Patel; Philip McGuire
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 7.348

5.  Attenuated psychosis syndrome: benefits of explicit recognition.

Authors:  Jason Schiffman; William T Carpenter
Journal:  Shanghai Arch Psychiatry       Date:  2015-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.